Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ABOS is expected to report earnings to fall 21.76% to -39 cents per share on March 31

Acumen Pharmaceuticals ABOS Stock Earnings Reports

Q4'24

Est.

$-0.39

Q3'24

Missed

by $0.14

Q2'24

Missed

by $0.07

Q1'24

Beat

by $0.01

Q4'23

Missed

by $0.11

The last earnings report on November 12 showed earnings per share of -50 cents, missing the estimate of -36 cents. With 202.92K shares outstanding, the current market capitalization sits at 156.81M.

View a ticker or compare two or three

Compare

ABOS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ABOS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

427 Park Street

Phone

+1 434 297-1000

Employees

Web

https://www.acumenpharm.com